{"id":"W2906996236","doi":"10.1182/blood-2018-99-116745","title":"Efficacy and Toxicity of JCAR014 in Combination with Durvalumab for the Treatment of Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Durvalumab; Medicine; Fludarabine; Cyclophosphamide; Internal medicine; Tolerability; Combination therapy; Refractory (planetary science); Immunotherapy; Oncology; Gastroenterology; Immunology; Pharmacology; Chemotherapy; Adverse effect; Cancer; Nivolumab; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001274621,0.0001220089,0.0002799431,0.0000944343,0.00004274291,0.000005220557,0.00006288446,0.00005675253,0.0000374944],"category_scores_gemma":[0.00003844243,0.00006772049,0.00003440973,0.0001666321,0.0002527184,0.00003371384,0.00001336248,0.00003947832,7.579654e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006585694,"about_ca_system_score_gemma":0.0001085894,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008644802,"about_ca_topic_score_gemma":0.00007130193,"domain_scores_codex":[0.9991082,0.00004545175,0.0001868487,0.0001911136,0.0003054811,0.0001628813],"domain_scores_gemma":[0.9988657,0.0003076008,0.0002056888,0.0002932496,0.000277411,0.00005030158],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04316767,0.05896732,0.6630809,0.0004451727,0.0009987527,0.00003006095,0.009940213,0.000005440892,0.0853777,0.00002863504,0.0000761121,0.1378821],"study_design_scores_gemma":[0.1073347,0.03961367,0.5694038,0.000200284,0.0002530854,0.000004477629,0.0001275515,0.00009511239,0.2826183,0.00001113181,0.0002466782,0.00009120921],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974875,0.0002395096,0.0000328616,0.00003896357,0.0000202555,0.001748509,0.00001886113,0.000006140679,0.00040742],"genre_scores_gemma":[0.9991757,0.0001310885,0.0002806178,0.00001288843,0.00003321757,0.00007242233,0.0000199645,0.00002278573,0.000251292],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1972406,"threshold_uncertainty_score":0.2761561,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01234072366315731,"score_gpt":0.2692520459626004,"score_spread":0.2569113222994431,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}